BioHarvest Sciences Inc (BHST)
6.293
+0.14
(+2.33%)
USD |
NASDAQ |
May 23, 16:00
6.13
-0.16
(-2.59%)
After-Hours: 20:00
Key Stats
Price and Performance | |
---|---|
Market Cap | 109.04M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -0.11% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 3.882 |
Price to Book Value | -- |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -8.558 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 99.99% |
Profile
Edit
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications. |
URL | https://www.bioharvest.com |
Investor Relations URL | N/A |
HQ State/Province | British Columbia |
Sector | Consumer Staples |
Industry | Personal Care Products |
Next Earnings Release | Aug. 29, 2025 (est.) |
Last Earnings Release | May. 15, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Edit
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications. |
URL | https://www.bioharvest.com |
Investor Relations URL | N/A |
HQ State/Province | British Columbia |
Sector | Consumer Staples |
Industry | Personal Care Products |
Next Earnings Release | Aug. 29, 2025 (est.) |
Last Earnings Release | May. 15, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |